194 related articles for article (PubMed ID: 28445885)
1. Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.
Taipa R; Brochado P; Robinson A; Reis I; Costa P; Mann DM; Melo Pires M; Sousa N
Neurodegener Dis; 2017; 17(4-5):145-154. PubMed ID: 28445885
[TBL] [Abstract][Full Text] [Related]
2. Patterns of microglial cell activation in frontotemporal lobar degeneration.
Lant SB; Robinson AC; Thompson JC; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Gerhard A; Mann DM
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):686-96. PubMed ID: 24117616
[TBL] [Abstract][Full Text] [Related]
3. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
[TBL] [Abstract][Full Text] [Related]
4. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
Sakae N; Roemer SF; Bieniek KF; Murray ME; Baker MC; Kasanuki K; Graff-Radford NR; Petrucelli L; Van Blitterswijk M; Rademakers R; Dickson DW
Ann Clin Transl Neurol; 2019 Sep; 6(9):1782-1796. PubMed ID: 31448566
[TBL] [Abstract][Full Text] [Related]
5. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
[TBL] [Abstract][Full Text] [Related]
9. Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.
Mao Q; Wang D; Li Y; Kohler M; Wilson J; Parton Z; Shmaltsuyeva B; Gursel D; Rademakers R; Weintraub S; Mesulam MM; Xia H; Bigio EH
J Neuropathol Exp Neurol; 2017 Nov; 76(11):957-968. PubMed ID: 29044416
[TBL] [Abstract][Full Text] [Related]
10. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Carter D; Cairns NJ
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
[TBL] [Abstract][Full Text] [Related]
11. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
[TBL] [Abstract][Full Text] [Related]
12. Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia.
Ohm DT; Kim G; Gefen T; Rademaker A; Weintraub S; Bigio EH; Mesulam MM; Rogalski E; Geula C
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):216-229. PubMed ID: 29679378
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
Hok-A-Hin YS; Hoozemans JJM; Hu WT; Wouters D; Howell JC; Rábano A; van der Flier WM; Pijnenburg YAL; Teunissen CE; Del Campo M
Alzheimers Res Ther; 2022 Jul; 14(1):100. PubMed ID: 35879733
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions.
Hasan R; Humphrey J; Bettencourt C; Newcombe J; ; Lashley T; Fratta P; Raj T
Acta Neuropathol; 2022 Mar; 143(3):383-401. PubMed ID: 34961893
[TBL] [Abstract][Full Text] [Related]
15. White matter pathology in sporadic frontotemporal lobar degeneration with TDP-43 proteinopathy.
Armstrong RA
Clin Neuropathol; 2017; 36 (2017)(2):66-72. PubMed ID: 28128723
[TBL] [Abstract][Full Text] [Related]
16. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
Foulds PG; Davidson Y; Mishra M; Hobson DJ; Humphreys KM; Taylor M; Johnson N; Weintraub S; Akiyama H; Arai T; Hasegawa M; Bigio EH; Benson FE; Allsop D; Mann DM
Acta Neuropathol; 2009 Nov; 118(5):647-58. PubMed ID: 19823856
[TBL] [Abstract][Full Text] [Related]
17. Typical and atypical pathology in primary progressive aphasia variants.
Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML
Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816
[TBL] [Abstract][Full Text] [Related]
18. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
[TBL] [Abstract][Full Text] [Related]
19. MRI signatures of the frontotemporal lobar degeneration continuum.
Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathology in primary progressive language and speech disorders.
Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
